PETRALLA, SABRINA
PETRALLA, SABRINA
ARAG - AREA FINANZA E PARTECIPATE
Collaboratori
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential
2019 Uliassi, Elisa; Pena-Altamira, Luis Emiliano; Morales, Aixa V.; Massenzio, Francesca; Petralla, Sabrina; Rossi, Michele; Roberti, Marinella; Martinez Gonzalez, Loreto; Martinez, Ana; Monti, Barbara; Bolognesi, Maria Laura*
A nutritional approach to tackle Alzheimer's disease: a key role for immunomodulation
2017 Altamira, LEP; Petralla, S; Massenzio, F; Parenti, C; Virgili, M; Bentivogli, M; Monti, B
Chronic treatment with hormonal contraceptives alters hippocampal BDNF and histone H3 post-translational modifications but not learning and memory in female rats
2022 Laura Boi, Sabrina Petralla, Barbara Monti, Giuseppe Talani, Enrico Sanna, Maria Giuseppina Pisu, Giulia Calderisi, Elisabetta Maciocco, Mariangela Serra, Alessandra Concas, Patrizia Porcu
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507)
2019 De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martini C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A.
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo
2019 Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profilo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B.
Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia
2021 Sabrina Petralla, Cristina Parenti, Valentina Ravaioli, Irene Fancello, Francesca Massenzio, Marco Virgili, Barbara Monti, Emiliano Pena-Altamira
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment
2019 Montanari S.; Mahmoud A.M.; Pruccoli L.; Rabbito A.; Naldi M.; Petralla S.; Moraleda I.; Bartolini M.; Monti B.; Iriepa I.; Belluti F.; Gobbi S.; Di Marzo V.; Bisi A.; Tarozzi A.; Ligresti A.; Rampa A.
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.
2019 De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A.
Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells.
2017 Profilo, E; Peña-Altamira, Le; Corricelli, M; Castegna, A; Danese, A; Agrimi, G; Petralla, S; Giannuzzi, G; Porcelli, V; Sbano, L; Viscomi, C; Massenzio, F; Palmieri, Em; Giorgi, C; Fiermonte, G; Virgili, M; Palmieri, L; Zeviani, M; Pinton, P; Monti, B; Palmieri, F; Lasorsa, Fm.
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
2019 Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M.; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M.
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches
2021 Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleonora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease
2021 Albertini C.; Naldi M.; Petralla S.; Strocchi S.; Grifoni D.; Monti B.; Bartolini M.; Bolognesi M.L.
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency
2022 Poeta E.; Petralla S.; Babini G.; Renzi B.; Celauro L.; Magnifico M.C.; Barile S.N.; Masotti M.; De Chirico F.; Massenzio F.; Viggiano L.; Palmieri L.; Virgili M.; Lasorsa F.M.; Monti B.
Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose
2018 Massenzio, Francesca; Peña-Altamira, Emiliano; Petralla, Sabrina; Virgili, Marco; Zuccheri, Giampaolo; Miti, Andrea; Polazzi, Elisabetta; Mengoni, Ilaria; Piffaretti, Deborah; Monti, Barbara*
N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study
2020 Marques C.S.; Lopez O.; Bagetta D.; Carreiro E.P.; Petralla S.; Bartolini M.; Hoffmann M.; Alcaro S.; Monti B.; Bolognesi M.L.; Decker M.; Fernandez-Bolanos J.G.; Burke A.J.
Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology.
2015 Polazzi, E; Mengoni, I; Peña-Altamira, E; Massenzio, F; Virgili, M; Petralla, S; Monti, B.
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease
2019 Romeiro L.A.S.; Da Costa Nunes J.L.; De Oliveira Miranda C.; Simoies Heyn Roth Cardoso G.; De Oliveira A.S.; Gandini A.; Kobrlova T.; Soukup O.; Rossi Michele.; Senger J.; Jung M.; Gervasoni S.; Vistoli G.; Petralla S.; Massenzio F.; Monti B.; Bolognesi M.L.
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease.
2017 Peña-Altamira, E; Petralla, S; Massenzio, F; Virgili, M; Bolognesi, Ml; Monti, B.
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease
2021 Gorecki L.; Uliassi E.; Bartolini M.; Janockova J.; Hrabinova M.; Hepnarova V.; Prchal L.; Muckova L.; Pejchal J.; Karasova J.Z.; Mezeiova E.; Benkova M.; Kobrlova T.; Soukup O.; Petralla S.; Monti B.; Korabecny J.; Bolognesi M.L.
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors
2019 Roldan-Pena J.M.; Romero-Real V.; Hicke J.; Maya I.; Franconetti A.; Lagunes I.; Padron J.M.; Petralla S.; Poeta E.; Naldi M.; Bartolini M.; Monti B.; Bolognesi M.; Lopez O.; Fernandez-Bolanos J.G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential | Uliassi, Elisa; Pena-Altamira, Luis Emiliano; Morales, Aixa V.; Massenzio, Francesca; Petralla, S...abrina; Rossi, Michele; Roberti, Marinella; Martinez Gonzalez, Loreto; Martinez, Ana; Monti, Barbara; Bolognesi, Maria Laura* | 2019-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | - |
| A nutritional approach to tackle Alzheimer's disease: a key role for immunomodulation | Altamira, LEP; Petralla, S; Massenzio, F; Parenti, C; Virgili, M; Bentivogli, M; Monti, B | 2017-01-01 | GLIA | - | 4.02 Riassunto (Abstract) | - |
| Chronic treatment with hormonal contraceptives alters hippocampal BDNF and histone H3 post-translational modifications but not learning and memory in female rats | Laura Boi, Sabrina Petralla, Barbara Monti, Giuseppe Talani, Enrico Sanna, Maria Giuseppina Pisu,... Giulia Calderisi, Elisabetta Maciocco, Mariangela Serra, Alessandra Concas, Patrizia Porcu | 2022-01-01 | HORMONES AND BEHAVIOR | - | 1.01 Articolo in rivista | Accepted manuscript _ Monti B.pdf |
| Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) | De Simone A.; La Pietra V.; Betari N.; Petragnani N.; Conte M.; Daniele S.; Pietrobono D.; Martin...i C.; Petralla S.; Casadei R.; Davani L.; Frabetti F.; Russomanno P.; Novellino E.; Montanari S.; Tumiatti V.; Ballerini P.; Sarno F.; Nebbioso A.; Altucci L.; Monti B.; Andrisano V.; Milelli A. | 2019-01-01 | ACS MEDICINAL CHEMISTRY LETTERS | - | 1.01 Articolo in rivista | - |
| Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo | Petralla S.; Pena-Altamira L.E.; Poeta E.; Massenzio F.; Virgili M.; Barile S.N.; Sbano L.; Profi...lo E.; Corricelli M.; Danese A.; Giorgi C.; Ostan R.; Capri M.; Pinton P.; Palmieri F.; Lasorsa F.M.; Monti B. | 2019-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-20-04486.pdf |
| Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia | Sabrina Petralla, Cristina Parenti, Valentina Ravaioli, Irene Fancello, Francesca Massenzio, Marc...o Virgili, Barbara Monti, Emiliano Pena-Altamira | 2021-01-01 | MOLECULAR NEUROBIOLOGY | - | 1.01 Articolo in rivista | - |
| Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment | Montanari S.; Mahmoud A.M.; Pruccoli L.; Rabbito A.; Naldi M.; Petralla S.; Moraleda I.; Bartolin...i M.; Monti B.; Iriepa I.; Belluti F.; Gobbi S.; Di Marzo V.; Bisi A.; Tarozzi A.; Ligresti A.; Rampa A. | 2019-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | benzo AM .pdf |
| Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. | De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Pe...tralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A. | 2019-01-01 | ACS MEDICINAL CHEMISTRY LETTERS | - | 1.01 Articolo in rivista | AM11585-685764.pdf |
| Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. | Profilo, E; Peña-Altamira, Le; Corricelli, M; Castegna, A; Danese, A; Agrimi, G; Petralla, S; Gia...nnuzzi, G; Porcelli, V; Sbano, L; Viscomi, C; Massenzio, F; Palmieri, Em; Giorgi, C; Fiermonte, G; Virgili, M; Palmieri, L; Zeviani, M; Pinton, P; Monti, B; Palmieri, F; Lasorsa, Fm. | 2017-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA | - | 1.01 Articolo in rivista | - |
| Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo | Scheiner M.; Dolles D.; Gunesch S.; Hoffmann M.; Nabissi M.; Marinelli O.; Naldi M.; Bartolini M....; Petralla S.; Poeta E.; Monti B.; Falkeis C.; Vieth M.; Hubner H.; Gmeiner P.; Maitra R.; Maurice T.; Decker M. | 2019-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | dual acting_am_ 730794.pdf |
| Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches | Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleon...ora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti | 2021-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | biomolecules-11-00306-v2.pdf |
| From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease | Albertini C.; Naldi M.; Petralla S.; Strocchi S.; Grifoni D.; Monti B.; Bartolini M.; Bolognesi M.L. | 2021-01-01 | MOLECULES | - | 1.01 Articolo in rivista | molecules-26-01112-v3.pdf |
| Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency | Poeta E.; Petralla S.; Babini G.; Renzi B.; Celauro L.; Magnifico M.C.; Barile S.N.; Masotti M.; ...De Chirico F.; Massenzio F.; Viggiano L.; Palmieri L.; Virgili M.; Lasorsa F.M.; Monti B. | 2022-01-01 | FRONTIERS IN CELLULAR NEUROSCIENCE | - | 1.01 Articolo in rivista | fncel-15-773709.pdf |
| Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose | Massenzio, Francesca; Peña-Altamira, Emiliano; Petralla, Sabrina; Virgili, Marco; Zuccheri, Giamp...aolo; Miti, Andrea; Polazzi, Elisabetta; Mengoni, Ilaria; Piffaretti, Deborah; Monti, Barbara* | 2018-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE | - | 1.01 Articolo in rivista | - |
| N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study | Marques C.S.; Lopez O.; Bagetta D.; Carreiro E.P.; Petralla S.; Bartolini M.; Hoffmann M.; Alcaro... S.; Monti B.; Bolognesi M.L.; Decker M.; Fernandez-Bolanos J.G.; Burke A.J. | 2020-01-01 | BIOORGANIC CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology. | Polazzi, E; Mengoni, I; Peña-Altamira, E; Massenzio, F; Virgili, M; Petralla, S; Monti, B. | 2015-01-01 | JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | - | 1.01 Articolo in rivista | - |
| Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease | Romeiro L.A.S.; Da Costa Nunes J.L.; De Oliveira Miranda C.; Simoies Heyn Roth Cardoso G.; De Oli...veira A.S.; Gandini A.; Kobrlova T.; Soukup O.; Rossi Michele.; Senger J.; Jung M.; Gervasoni S.; Vistoli G.; Petralla S.; Massenzio F.; Monti B.; Bolognesi M.L. | 2019-01-01 | ACS MEDICINAL CHEMISTRY LETTERS | - | 1.01 Articolo in rivista | - |
| Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. | Peña-Altamira, E; Petralla, S; Massenzio, F; Virgili, M; Bolognesi, Ml; Monti, B. | 2017-01-01 | FRONTIERS IN AGING NEUROSCIENCE | - | 1.01 Articolo in rivista | - |
| Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease | Gorecki L.; Uliassi E.; Bartolini M.; Janockova J.; Hrabinova M.; Hepnarova V.; Prchal L.; Muckov...a L.; Pejchal J.; Karasova J.Z.; Mezeiova E.; Benkova M.; Kobrlova T.; Soukup O.; Petralla S.; Monti B.; Korabecny J.; Bolognesi M.L. | 2021-01-01 | ACS CHEMICAL NEUROSCIENCE | - | 1.01 Articolo in rivista | - |
| Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors | Roldan-Pena J.M.; Romero-Real V.; Hicke J.; Maya I.; Franconetti A.; Lagunes I.; Padron J.M.; Pet...ralla S.; Poeta E.; Naldi M.; Bartolini M.; Monti B.; Bolognesi M.; Lopez O.; Fernandez-Bolanos J.G. | 2019-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |